Correlation Between Wave Life and Transcode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Wave Life and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wave Life and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wave Life Sciences and Transcode Therapeutics, you can compare the effects of market volatilities on Wave Life and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wave Life with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wave Life and Transcode Therapeutics.

Diversification Opportunities for Wave Life and Transcode Therapeutics

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Wave and Transcode is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Wave Life Sciences and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Wave Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wave Life Sciences are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Wave Life i.e., Wave Life and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Wave Life and Transcode Therapeutics

Considering the 90-day investment horizon Wave Life Sciences is expected to generate 0.37 times more return on investment than Transcode Therapeutics. However, Wave Life Sciences is 2.71 times less risky than Transcode Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  547.00  in Wave Life Sciences on August 31, 2024 and sell it today you would earn a total of  952.00  from holding Wave Life Sciences or generate 174.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Wave Life Sciences  vs.  Transcode Therapeutics

 Performance 
       Timeline  
Wave Life Sciences 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Wave Life Sciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Wave Life exhibited solid returns over the last few months and may actually be approaching a breakup point.
Transcode Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Wave Life and Transcode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Wave Life and Transcode Therapeutics

The main advantage of trading using opposite Wave Life and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wave Life position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.
The idea behind Wave Life Sciences and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios